Search Results
May 20, 2026, 14:36 ET CureDuchenne Appoints Lidia Gardner, PhD, EMBA, as Vice President of Clinical and Medical Affairs to Advance Patient-Centered Care, Research, and Strategic Partnerships
Neurology & Immunology at EMD Serono, a business of Merck KGaA, Darmstadt, Germany. In that role, she led global medical strategy for neuroimmunology programs and collaborated across clinical development, regulatory, real-world evidence, and commercial teams. Prior to joining EMD Serono, she worked in Medical
More news about: CureDuchenne
May 19, 2026, 16:00 ET NIIMBL Announces 8 New Technology and Workforce Projects
ProjectsProject: Continuous and Automated Downstream Purification of AAVLead: Michigan Technological UniversityParticipants: Cytiva, EMD Millipore Corporation, Janssen, Landmark Bio, and PAK BioSolutionsProject: Leveraging Multidimensional Partner Data to Develop Predictive Digital
More news about: National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)
Apr 29, 2026, 16:04 ET Bramshill Investments' Portfolio Manager, Arif Joshi, featured on Bloomberg Intelligence FICC Focus
his 15 years at Lazard, he grew the EMD platform to $18bn of AUM, across both long-only and total return strategies. Arif served as a portfolio manager for both USD and local currency strategies and was also responsible for top-down macroeconomic views for the EMD platform. Prior to Lazard, Arif was
More news about: Bramshill Investments, LLC
Apr 22, 2026, 10:00 ET Lupus Advocates Take Action on Capitol Hill to Ensure Access to Care and Increase Research Funding
generous donors, and corporate partners whose support helped make the 2026 National Lupus Advocacy Summit possible: AstraZeneca, Biogen, Cabaletta Bio, EMD Serono, Genentech, GSK, Novartis, PhRMA, UCB, and Viatris.About the Lupus Foundation of AmericaThe Lupus Foundation of America is
More news about: Lupus Foundation of America, Inc.
Apr 09, 2026, 03:25 ET Aktia Bank Plc expands its distribution network in Europe through three new sales partnerships
Luxembourg: Oceanside Capital PartnersOceanside Capital Partners has represented Aktia's EMD strategies in the Netherlands since autumn 2025. We are now pleased to announce that coverage of both our EMD and Credit strategies is expanding to Belgium and Luxembourg."We are delighted to further
More news about: Aktia Bank
Apr 07, 2026, 07:45 ET TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations
privately funded $305M Series F funding round. Prior, Mrs. Garofalo was the Head of Oncology Delivery, Clinical Delivery & Patient Centricity at EMD Serono where she was responsible for a portfolio of over 200+ Oncology Ph I-IV sponsored and non-sponsored clinical trials, managed access programs,
More news about: TuHURA Biosciences, Inc.
Mar 02, 2026, 17:31 ET Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
drug profiles, including clinical and non-clinical stage products, and the key BTC companies, including Yantai Rongchang Pharmaceutical, RemeGen, EMD Serono, SMT bio Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., InnoPharmax Inc., Lee's Pharmaceutical Limited, Hoffmann-La Roche, Shanghai
More news about: DelveInsight Business Research, LLP
Feb 11, 2026, 17:31 ET EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
Innovative Medicine, Betta Pharma/Xcovery, CStone Pharmaceuticals, Bristol-Myers Squibb, Haihe Biopharma, Taiho Pharmaceutical, Takeda Pharmaceuticals, EMD Serono (Merck KGaA), Eli Lilly and Company, Merck, Regeneron/Sanofi, Ono Pharmaceutical, Novartis, Genentech/Roche, Amgen, Chugai Laboratories, Moderna
More news about: DelveInsight Business Research, LLP
Feb 10, 2026, 03:04 ET Merck India hosts 6th Merck-Tagore Award: Honours Professor Dr. Lars-Christian Koch for Promoting Intercultural Exchange between India and Germany
The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.All Merck press releases are distributed by e-mail at the same time they become available on the Merck
More news about: Merck India
Jan 26, 2026, 19:00 ET Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
(sCR), 7 very good partial responses (VGPR), and 9 partial responses (PR). In this cohort, the ORR was 80% among 10 patients with extramedullary disease (EMD) and 77.8% among 9 patients previously treated with BCMA- and/or GPRC5D-directed therapies. Among patients who achieved complete response or better,
More news about: Innovent Biologics
Jan 26, 2026, 17:31 ET RET Fusion Targeted Therapies Market Set for Robust Growth by 2034 Amid Precision Oncology Shift | DelveInsight
including clinical and non-clinical stage products, and the key non-small cell lung cancer companies, including BridgeBio Pharma, Daiichi Sankyo, EMD Serono, Merck, BridgeBio Pharma, Abbvie, Pfizer, Eli Lilly and Company BioNTech SE, Shenzhen TargetRx, Taiho Pharmaceutical, Chong Kun Dang, Bristol
More news about: DelveInsight Business Research, LLP
Jan 21, 2026, 16:10 ET CPKC investing US$800 million in American manufacturing with Tier 4 locomotives
this year for CPKC at the company's manufacturing facility in Dallas, Texas.In the second half of 2026, CPKC expects to take delivery of 30 new EMD® SD70ACe-T4 Tier 4 freight locomotives to be manufactured at Progress Rail's facility in Muncie, Indiana. These locomotives are part of an order for
More news about: CPKC
Dec 22, 2025, 14:26 ET 3M to showcase industry-advancing solutions, new AI-powered innovation tool at CES 2026
conversation hosted by the National Association of Manufacturers (NAM) and the Manufacturing Leadership Council (MLC), global leaders from 3M, EY, and EMD Electronics will discuss how their companies are transforming production, innovation, and supply chains in response to the convergence of consumer technology
More news about: 3M Company
Dec 18, 2025, 08:24 ET We Are ILL Concludes Sixth Annual Wellness Week(end) in Atlanta -- A Transformative Gathering for Black Women Living with Autoimmune Diseases
Dr. Sheyi Ayeni, Dallas Burleson, Denise Bronner, Lyndsey Odd-Williams, Lynnette Odd, and Yvonne Smith.SponsorsGold: Biogen, EMD Serono, NovartisSilver: Sanofi, Genentech, AbbVie, AlexionAbout We Are ILLWe Are ILL is a national nonprofit dedicated
More news about: We Are ILL
Dec 15, 2025, 17:47 ET Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime
additive manufacturing utilizing their Titomic Kinetic Fusion™ technology, is pleased to announce it has secured an Early Manufacturing Development (EMD) contract with a leading defense prime contractor to support a new effort for production of next-generation defense articles. The collaboration will
More news about: Titomic
Dec 15, 2025, 17:40 ET Titomic Secures Early Manufacturing Development Contract with Leading Defense Prime
additive manufacturing utilizing their Titomic Kinetic Fusion™ technology, is pleased to announce it has secured an Early Manufacturing Development (EMD) contract with a leading defense prime contractor to support a new effort for production of next-generation defense articles. The collaboration will
More news about: Titomic
Dec 07, 2025, 21:00 ET Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
in difficult-to-treat RRMM subgroups.Extramedullary disease (EMD): ORR 75.0%, including two sCRs. At 1200 μg/kg, ORR in EMD patients reached 100%, with rapid EMD lesion regression observed.Prior BCMA-treated patients: ORR 85.7%,
More news about: Leads Biolabs
Dec 07, 2025, 20:57 ET IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
sustained MRD negativity for over 24 months. In high-risk patient groups, including those with double-hit/triple-hit cytogenetics and R-ISS stage III with EMD, Eque-cel continued to demonstrate durable disease control, achieving a 24-month PFS rate of 74.5%. This suggests that this therapy could be a promising
More news about: IASO Bio
Dec 07, 2025, 20:02 ET ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
relatively short follow-up duration, IBI3003 has shown encouraging efficacy signals, particularly in high-risk patients with extramedullary disease (EMD) or those who have previously received anti-BCMA and/or anti-GPRC5D targeted therapies. IBI3003 is a novel trispecific antibody targeting GPRC5D,
More news about: Innovent Biologics
Nov 20, 2025, 07:42 ET High-Performance Supercomputer Launched to Advance AI Innovation and Scientific Discovery
the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany, operate as MilliporeSigma in life science, EMD Serono in healthcare and EMD Electronics in electronics. Since its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company's
More news about: Equinix, Inc.
Nov 13, 2025, 07:42 ET Domain Therapeutics Appoints Boston-Based Pharma Leader Jean-Marie Cuillerot, M.D., as Chief Medical Officer
Phase II and III clinical trials across multiple indications and supported regulatory filings in the United States and Europe. At EMD Serono, an affiliate of Merck Serono, Dr Cuillerot held senior leadership positions as Global Head of Clinical Development in Immuno-Oncology and later
More news about: Domain Therapeutics
Nov 10, 2025, 10:52 ET Propy completes first acquisition under its $100M AI roll-up strategy, entering Alabama
achieved despite fully manual operations. From calculating commission checks to reconciling ledgers, preparing closing disclosures, and manually tracking EMD deposits, the company's team has handled every detail by hand. "I didn't want to be left behind when AI started taking over.
More news about: Propy
Oct 23, 2025, 17:31 ET Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight
report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key gastric cancer companies, including EMD Serono, Sumitomo Pharma, LintonPharm Co., Ltd., Rapa Therapeutics LLC, Jiangsu HengRui Medicine Co., Ltd., Janssen Pharmaceutical K.K., Genentech, Exelixis,
More news about: DelveInsight Business Research, LLP
Oct 21, 2025, 11:42 ET Costa Rica estuvo presente en la feria más prestigiosa de la industria de semiconductores
ejecutivos. Algunas empresas de renombre mundial que estuvieron junto con el Ministro costarricense como panelistas en diversos foros fueron NVIDIA, EMD Electronics, IBM, Merk KGaA, TEL America, TSMC, entre otras. Actualmente, Costa Rica alberga a algunas de las empresas que estuvieron
More news about: PROCOMER
Oct 21, 2025, 11:39 ET Costa Rica Showcased Its Strength at the World's Leading Semiconductor Industry Fair
presentation during the event, with Minister of Foreign Trade Manuel Tovar participating in executive panels. Distinguished global companies such as NVIDIA, EMD Electronics, IBM, Merck KGaA, TEL America, and TSMC joined Minister Tovar as panelists in various discussions. Costa Rica is already
More news about: PROCOMER